[HTML][HTML] Soluble urokinase receptors in focal segmental glomerulosclerosis: a review on the scientific point of view
A Kronbichler, MA Saleem, B Meijers… - Journal of immunology …, 2016 - hindawi.com
Focal segmental glomerulosclerosis (FSGS) is one of the primary glomerular disorders in
both children and adults which can progress to end-stage renal failure. Although there are …
both children and adults which can progress to end-stage renal failure. Although there are …
[HTML][HTML] A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
JM Spinale, LH Mariani, S Kapoor, J Zhang… - Kidney international, 2015 - Elsevier
It has been suggested that soluble urokinase receptor (suPAR) is a causative circulating
factor for and a biomarker of focal and segmental glomerulosclerosis (FSGS). Here we …
factor for and a biomarker of focal and segmental glomerulosclerosis (FSGS). Here we …
Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis
T Shuai, YP Jing, Q Huang, H Xiong, J Liu, L Zhu… - BMJ open, 2019 - bmjopen.bmj.com
Objectives Soluble urokinase plasminogen activated receptor (suPAR) is a biomarker that
may predict the occurrence of focal segmental glomerulosclerosis (FSGS); however, there is …
may predict the occurrence of focal segmental glomerulosclerosis (FSGS); however, there is …
Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis
C Musetti, M Quaglia, T Cena, A Chiocchetti… - Journal of …, 2015 - Springer
Background Circulating levels of soluble urokinase-like plasminogen activator receptor
(suPAR) have been associated with proteinuria and renal function in focal segmental …
(suPAR) have been associated with proteinuria and renal function in focal segmental …
不同剂量低分子肝素联合泼尼松治疗难治性肾病综合征的临床研究
许国兵 - 现代药物与临床, 2015 - cqvip.com
目的探讨不同剂量低分子肝素联合泼尼松治疗难治性肾病综合征的临床疗效. 方法选取2012 年9
月—2014 年4 月岳阳市一人民医院收治的难治性肾病综合征患者128 例, 随机分为对照组和低 …
月—2014 年4 月岳阳市一人民医院收治的难治性肾病综合征患者128 例, 随机分为对照组和低 …
不同剂量低分子肝素对难治性肾病综合征高凝状态的影响
李妍， 沈军， 赵久阳 - 实用医学杂志, 2015 - cqvip.com
目的: 探讨不同剂量低分子肝素对难治性肾病综合征(RNS) 高凝状态的影响及不良反应. 方法:
选取2011 年9 月至2013 年9 月在我院治疗的80 例RNS 患者. 按入院的先后随机分为大剂量组 …
选取2011 年9 月至2013 年9 月在我院治疗的80 例RNS 患者. 按入院的先后随机分为大剂量组 …
[HTML][HTML] Patients with combined membranous nephropathy and focal segmental glomerulosclerosis have comparable clinical and autoantibody profiles with primary …
Q Gu, Z Cui, J Huang, YM Zhang, Z Qu, F Wang… - Medicine, 2016 - journals.lww.com
Patients with combined membranous nephropathy (MN) and focal segmental
glomerulosclerosis (FSGS) have been reported with different clinical significance …
glomerulosclerosis (FSGS) have been reported with different clinical significance …
Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic …
N Roca, E Jatem, ML Martín, M Munoz… - Clinical Kidney …, 2021 - academic.oup.com
Background Serum levels of soluble urokinase-type plasminogen activator receptor (suPAR)
are high in some patients with idiopathic nephrotic syndrome (INS). Given that suPAR …
are high in some patients with idiopathic nephrotic syndrome (INS). Given that suPAR …
血浆可溶性尿激酶型纤溶酶原激活剂受体在原发性局灶节段性肾小球硬化症患者病情评估中的作用
李月红， 林则行， 燕宇， 李松 - 临床内科杂志, 2016 - cqvip.com
目的探讨血浆可溶性尿激酶型纤溶酶原激活剂受体(suPAR) 在原发性局灶节段性肾小球硬化症(
FSGS) 患者病情评估中的作用. 方法回顾性分析经肾活检诊断为原发性FSGS 患者92 …
FSGS) 患者病情评估中的作用. 方法回顾性分析经肾活检诊断为原发性FSGS 患者92 …
Minimal Change Disease and Focal Segmental Glomerulosclerosis in Adults
Y Zhang, J Lv - Evidence‐Based Nephrology, 2022 - Wiley Online Library
Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are the two
key forms of idiopathic nephrotic syndrome. This chapter examines the evidence for …
key forms of idiopathic nephrotic syndrome. This chapter examines the evidence for …